Inventor
HUKELMANN JENS
DE12 patents
Patents
12 patentsUS12318407B2Jun 3, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12290530B2May 6, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12285443B2Apr 29, 2025
Peptides displayed by HLA for use immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12274716B2Apr 15, 2025
Peptides displayed by HLA for use immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12257269B2Mar 25, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12246039B2Mar 11, 2025
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11957716B2Apr 16, 2024
Peptides displayed by HLA for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11969464B2Apr 30, 2024
Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11904003B2Feb 20, 2024
Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11833195B2Dec 5, 2023
Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations61
US11952409B2Apr 9, 2024
Amidated peptides and their deamidated counterparts displayed by non-HLA-A*02 for use in immunotherapy against different types of cancers preliminary class
IMMATICS BIOTECHNOLOGIES GMBH0 citations59
US11891427B2Feb 6, 2024
Amidated peptides and their deamidated counterparts displayed by non-HLA-a*02 for use in immunotherapy against different types of cancers
IMMATICS BIOTECHNOLOGIES GMBH0 citations59